Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Winkler

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Prostate Cancer and Prostatic Diseases|January 28, 2021
Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched studyTaimur T Shah, Deepika Reddy, Max Peters, et al.
European Urology|April 22, 2020
Additional Value of Dynamic Contrast-enhanced Sequences in Multiparametric Prostate Magnetic Resonance Imaging: Data from the PROMIS StudyAhmed El-Shater Bosaily, Elena Frangou, Hashim U Ahmed, et al.
Radiology|December 13, 2022
Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS TrialVasilis Stavrinides, Joseph M Norris, Solon Karapanagiotis, et al.
European Urology|November 8, 2025
Five-year Outcomes for Men after Negative Magnetic Resonance Imaging (MRI) or Negative Biopsy in the RAPID MRI-directed Prostate Cancer Diagnostic PathwayChase Peng Yun Ng, Alexander Light, Sai Kalpitha Eragamreddy, et al.
European Urology|October 14, 2020
False Positive Multiparametric Magnetic Resonance Imaging Phenotypes in the Biopsy-naïve Prostate: Are They Distinct from Significant Cancer-associated Lesions? Lessons from PROMISVasilis Stavrinides, Tom Syer, Yipeng Hu, et al.
European Urology|August 13, 2022
Predicting the Need for Biopsy to Detect Clinically Significant Prostate Cancer in Patients with a Magnetic Resonance Imaging-detected Prostate Imaging Reporting and Data System/Likert ≥3 Lesion: Development and Multinational External Validation of the Imperial Rapid Access to Prostate Imaging and Diagnosis Risk ScoreMax Peters, David Eldred-Evans, Piet Kurver, et al.
BMJ Open|February 26, 2021
Additional Treatments to the Local tumour for metastatic prostate cancer-Assessment of Novel Treatment Algorithms (IP2-ATLANTA): protocol for a multicentre, phase II randomised controlled trialMartin John Connor, Taimur Tariq Shah, Katarzyna Smigielska, et al.
BJU International|June 10, 2026
Delphi consensus on ex vivo fluorescence confocal microscopy in robot-assisted radical prostatectomyEdoardo Beatrici, Mario de Angelis, Ricardo Almeida-Magana, et al.
Science Translational Medicine|July 15, 2021
Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancerStelios Chrysostomou, Rajat Roy, Filippo Prischi, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Prostate Cancer and Prostatic Diseases|January 28, 2021
Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched studyTaimur T Shah, Deepika Reddy, Max Peters, et al.
European Urology|April 22, 2020
Additional Value of Dynamic Contrast-enhanced Sequences in Multiparametric Prostate Magnetic Resonance Imaging: Data from the PROMIS StudyAhmed El-Shater Bosaily, Elena Frangou, Hashim U Ahmed, et al.
Radiology|December 13, 2022
Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS TrialVasilis Stavrinides, Joseph M Norris, Solon Karapanagiotis, et al.
European Urology|November 8, 2025
Five-year Outcomes for Men after Negative Magnetic Resonance Imaging (MRI) or Negative Biopsy in the RAPID MRI-directed Prostate Cancer Diagnostic PathwayChase Peng Yun Ng, Alexander Light, Sai Kalpitha Eragamreddy, et al.
European Urology|October 14, 2020
False Positive Multiparametric Magnetic Resonance Imaging Phenotypes in the Biopsy-naïve Prostate: Are They Distinct from Significant Cancer-associated Lesions? Lessons from PROMISVasilis Stavrinides, Tom Syer, Yipeng Hu, et al.
European Urology|August 13, 2022
Predicting the Need for Biopsy to Detect Clinically Significant Prostate Cancer in Patients with a Magnetic Resonance Imaging-detected Prostate Imaging Reporting and Data System/Likert ≥3 Lesion: Development and Multinational External Validation of the Imperial Rapid Access to Prostate Imaging and Diagnosis Risk ScoreMax Peters, David Eldred-Evans, Piet Kurver, et al.
BMJ Open|February 26, 2021
Additional Treatments to the Local tumour for metastatic prostate cancer-Assessment of Novel Treatment Algorithms (IP2-ATLANTA): protocol for a multicentre, phase II randomised controlled trialMartin John Connor, Taimur Tariq Shah, Katarzyna Smigielska, et al.
BJU International|June 10, 2026
Delphi consensus on ex vivo fluorescence confocal microscopy in robot-assisted radical prostatectomyEdoardo Beatrici, Mario de Angelis, Ricardo Almeida-Magana, et al.
Science Translational Medicine|July 15, 2021
Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancerStelios Chrysostomou, Rajat Roy, Filippo Prischi, et al.
Pageof 10